-
Subject Areas on Research
-
"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.
-
'I'll do what they did": social norm information and cancer treatment decisions.
-
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies.
-
3D image guidance assisted identification of colorectal cancer liver metastases not seen on intraoperative ultrasound: results from a prospective trial.
-
A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women With Stage IIIC Endometrial Cancer.
-
A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer.
-
A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer.
-
A general formulation for a one-sided group sequential design.
-
A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma.
-
A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.
-
A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
-
A multigene prognostic assay for selection of adjuvant chemotherapy in patients with T3, stage II colon cancer: impact on quality-adjusted life expectancy and costs.
-
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
-
A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254.
-
A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235).
-
A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases.
-
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.
-
A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation.
-
A safety and survival analysis of neoadjuvant bevacizumab with standard chemoradiation in a phase I/II study compared with standard chemoradiation in locally advanced rectal cancer.
-
A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery.
-
AGA Technical Review on Systemic Therapies for Hepatocellular Carcinoma.
-
ASO Visual Abstract: Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy?
-
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
-
Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527.
-
Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy.
-
Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation.
-
Acute coronary syndromes and diabetes mellitus.
-
Adenocarcinoma Ex-Goblet Cell: a Retrospective Experience.
-
Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma.
-
Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104.
-
Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data.
-
Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income.
-
Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women.
-
Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
-
Adjunctive brexpiprazole for the treatment of major depressive disorder.
-
Adjuvant Chemotherapy After Lobectomy for T1-2N0 Non-Small Cell Lung Cancer: Are the Guidelines Supported?
-
Adjuvant Chemotherapy After Preoperative Chemoradiation Improves Survival in Patients With Locally Advanced Rectal Cancer.
-
Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors.
-
Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete Response.
-
Adjuvant Chemotherapy Versus Observation Following Resection for Patients With Nonmetastatic Poorly Differentiated Colorectal Neuroendocrine Carcinomas.
-
Adjuvant Chemotherapy for Stage II Rectal Cancer.
-
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
-
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up.
-
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
-
Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results.
-
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.
-
Adjuvant Systemic Therapies for Patients with Renal Cell Carcinoma: Choosing Treatment Based on Patient-level Characteristics.
-
Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis.
-
Adjuvant chemotherapy for breast cancer in older women: emerging evidence to aid in decision making.
-
Adjuvant chemotherapy for colorectal hepatic metastases: role of route of administration and timing.
-
Adjuvant chemotherapy for non-small cell lung cancer.
-
Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection.
-
Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomes.
-
Adjuvant chemotherapy for t1 node-positive colon cancers provides significant survival benefit.
-
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.
-
Adjuvant chemotherapy in older women with early-stage breast cancer.
-
Adjuvant chemotherapy is associated with improved survival after esophagectomy without induction therapy for node-positive adenocarcinoma.
-
Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer.
-
Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence.
-
Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience.
-
Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases.
-
Adjuvant high-dose interferon therapy for high-risk melanoma.
-
Adjuvant hormonal therapy use among insured, low-income women with breast cancer.
-
Adjuvant hormonal therapy use among women with ductal carcinoma in situ.
-
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.
-
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.
-
Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
-
Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter.
-
Adjuvant sequential chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil (ACMF) with concurrent radiotherapy in resectable advanced breast cancer.
-
Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial.
-
Adjuvant therapy for colorectal cancer.
-
Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
-
Adjuvant therapy for pancreatic cancer: an evolving paradigm.
-
Adjuvant therapy for pancreatic cancer: current status and future directions.
-
Adjuvant therapy for surgically resected pancreatic adenocarcinoma.
-
Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
-
Adjuvant therapy of pancreatic cancer.
-
Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging.
-
Adjuvant trazodone in the treatment of alcoholism: an open study.
-
Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer.
-
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
-
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.
-
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.
-
Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101.
-
Aggressive multimodality treatment of invasive thymic carcinoma.
-
Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults.
-
Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy.
-
An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
-
Anal cancer. American College of Radiology. ACR Appropriateness Criteria.
-
Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114.
-
Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases.
-
Anthracycline-induced cardiotoxicity in patients with early-stage breast cancer: the Canadian Cancer Trials Group (CCTG) MA.21 experience.
-
Anthracyclines in the treatment of early-stage breast cancer: ally or adversary?
-
Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma.
-
Appendiceal carcinoma: patterns of failure following surgery and implications for adjuvant therapy.
-
Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804.
-
Applying the neoadjuvant paradigm to ductal carcinoma in situ.
-
Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer.
-
Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.
-
Assessment of multimodality therapy use for extremity sarcoma in the United States.
-
Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
-
Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer.
-
Association of 21-Gene Assay (OncotypeDX) Testing and Receipt of Chemotherapy in the Medicare Breast Cancer Patient Population Following Initial Adoption.
-
Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy.
-
Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial.
-
Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803.
-
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
-
BMI influences prognosis following surgery and adjuvant chemotherapy for lymph node positive breast cancer.
-
Benefit of adjuvant chemotherapy after resection of stage II (T1-2N1M0) non-small cell lung cancer in elderly patients.
-
Bevacizumab-associated fistula formation in postoperative colorectal cancer patients.
-
Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy.
-
Bladder cancer. Clinical practice guidelines in oncology.
-
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.
-
CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases.
-
Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer.
-
Cancer care quality measures: diagnosis and treatment of colorectal cancer.
-
Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.
-
Carboplatin chemotherapy for progressive intramedullary spinal cord low-grade gliomas in children: three case studies and a review of the literature.
-
Carboplatin, etoposide, and radiotherapy, followed by surgery, for the treatment of marginally resectable non-small cell lung cancer.
-
Cardiorespiratory fitness in breast cancer patients: a call for normative values.
-
Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial.
-
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer.
-
Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy.
-
Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer.
-
Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
-
Chemoradiation for localized pancreatic cancer: another perspective.
-
Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue.
-
Chemotherapy Costs and 21-Gene Recurrence Score Genomic Testing Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005 to 2011.
-
Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface.
-
Chemotherapy for adults with malignant glioma.
-
Chemotherapy in the elderly.
-
Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer.
-
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).
-
Clear cell adenocarcinoma in a female urethral diverticulum.
-
Clinical Impact of 21-Gene Recurrence Score Test Within the Veterans Health Administration: Utilization and Receipt of Guideline-Concordant Care.
-
Clinical Trials of Systemic Chemotherapy for Resectable Pancreatic Cancer: A Review.
-
Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point.
-
Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.
-
Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience.
-
Clinicopathological characteristics and treatment of rhabdoid glioblastoma.
-
Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance).
-
Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).
-
Colorectal cancer.
-
Colorectal cancer: adjuvant chemotherapy for rectal cancer-an unresolved issue.
-
Combined modality therapy for rectal and colon cancer.
-
Combined modality treatment for rectal cancer.
-
Combined treatment approaches in regionally advanced bladder cancer.
-
Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
-
Combining targeted agents with modern radiotherapy in soft tissue sarcomas.
-
Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance).
-
Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy.
-
Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer.
-
Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.
-
Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis.
-
Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).
-
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
-
Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival.
-
Complications of pancreaticoduodenectomy after neoadjuvant chemoradiation in patients with and without preoperative biliary drainage.
-
Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer.
-
Congenital neuroepithelioma in an infant hand.
-
Controversies in the treatment of prostate cancer with maximal androgen deprivation.
-
Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results.
-
Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis.
-
Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.
-
Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix.
-
Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy.
-
Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer.
-
CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.
-
Current Trends in the Management of Ductal Carcinoma In Situ.
-
Current management of adrenal tumors.
-
Cutaneous Metastasis of a Mucoepidermoid Carcinoma of the Pancreas: First Reported Case.
-
Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis.
-
DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: a pilot study.
-
Defining the Place of Adjuvant Chemotherapy and Radiation for High-Risk Endometrial Cancer From Recent Randomized Clinical Trials: Some Answers, More Questions.
-
Defining the role of adjuvant chemotherapy after lobectomy for typical bronchopulmonary carcinoid tumors.
-
Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer.
-
Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy?
-
Delayed-type hypersensitivity reaction with iscador M given in combination with cytotoxic chemotherapy.
-
Desmoid tumors of the chest wall.
-
Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases.
-
Determining the Optimal Timing for Initiation of Adjuvant Chemotherapy After Resection for Stage II and III Colon Cancer.
-
Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer.
-
Diagnosis and treatment of stage-III peripheral squamous cell carcinoma of right upper lung.
-
Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance).
-
Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581.
-
Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?
-
Does postoperative irradiation play a role in the adjuvant therapy of stage T4 colon cancer?
-
Does radiologic response correlate to pathologic response in patients undergoing neoadjuvant therapy for borderline resectable pancreatic malignancy?
-
Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study.
-
Does vocal cord fixation preclude nonsurgical management of laryngeal cancer?
-
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel.
-
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
-
Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype.
-
Early breast cancer therapy and cardiovascular injury.
-
Early prostate cancer: the national results of radiation treatment from the Patterns of Care and Radiation Therapy Oncology Group studies with prospects for improvement with conformal radiation and adjuvant androgen deprivation.
-
Economic analysis of gene expression profile data to guide adjuvant treatment in women with early-stage breast cancer.
-
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
-
Effect of age on the efficacy of adjuvant chemotherapy for resected non-small cell lung cancer.
-
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials.
-
Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life.
-
Effect of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy.
-
Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.
-
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial.
-
Effects of chemotherapy and tamoxifen on cervical and vaginal smears in bone marrow transplant recipients.
-
Efficacy of autologous blood injection for treating overfiltering or leaking blebs after glaucoma surgery.
-
Endocrine therapy in early-stage breast cancer care: defining the appropriate regimen and time frame.
-
Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal women with hormone receptor-positive advanced breast cancer-CALGB 40302 (Alliance).
-
Equivalent Treatment and Survival after Resection of Pancreatic Cancer at Safety-Net Hospitals.
-
Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer.
-
Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram.
-
Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases.
-
Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution.
-
Ewing's sarcoma of the hand.
-
Ex vivo evaluation of preoperatively treated rectal cancer specimens of patients undergoing radical resection.
-
Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials.
-
Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma.
-
External beam radiation therapy for clinically localized prostate cancer: when and how we optimize with concurrent hormonal deprivation.
-
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.
-
Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer.
-
Factors influencing Oncotype DX use in the management of early breast cancer: a single centre experience.
-
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.
-
Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates.
-
Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors.
-
Fibromatoses in childhood: the desmoid/fibromatosis complex.
-
Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.
-
Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer.
-
Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation.
-
Gefitinib therapy for non-small cell lung cancer.
-
Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy.
-
Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.
-
Glutathione-s-transferase-pi expression in early breast cancer: association with outcome and response to chemotherapy.
-
Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer.
-
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.
-
Health-related quality of life in long-term breast cancer survivors: differences by adjuvant chemotherapy dose in Cancer and Leukemia Group B study 8541.
-
Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer.
-
High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.
-
Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer.
-
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome.
-
How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support.
-
ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings.
-
Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer.
-
Identification of distinct and overlapping cortical areas for bilingual naming and reading using cortical stimulation. Case report.
-
Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC Study.
-
Immune thrombocytopenic purpura (ITP) and breast cancer. Does adjuvant therapy for breast cancer improve platelet counts in ITP?
-
Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial.
-
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.
-
Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.
-
Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies.
-
Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) study.
-
Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.
-
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
-
Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction.
-
Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer.
-
Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
-
Impact of minimally invasive gastrectomy on use of and time to adjuvant chemotherapy for gastric adenocarcinoma.
-
Impact of minimally invasive vs. open distal pancreatectomy on use of adjuvant chemoradiation for pancreatic adenocarcinoma.
-
Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.
-
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
-
Impact of postoperative nausea and vomiting prophylaxis with dexamethasone on the risk of recurrence of endometrial cancer.
-
Improved overall survival is still observed in patients receiving delayed adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
-
Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial.
-
Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.
-
Improving understanding of adjuvant therapy options by using simpler risk graphics.
-
Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy.
-
Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices.
-
Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results.
-
Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trials.
-
Individual responses to chemotherapy-induced oxidative stress.
-
Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B.
-
Induction chemotherapy: to use or not to use? That is the question.
-
Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
-
Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).
-
Inflammation and Clinical Decline After Adjuvant Chemotherapy in Older Adults With Breast Cancer: Results From the Hurria Older Patients Prospective Study.
-
Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
-
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.
-
Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
-
Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer.
-
Initiation of salvage therapy for prostate cancer.
-
Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO).
-
Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
-
Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.
-
Intensive outpatient adjuvant therapy for breast cancer: results of dose escalation and quality of life.
-
Interferon Alfa-2b or not 2b? Significant differences exist in the decision-making process between melanoma patients who accept or decline high-dose adjuvant interferon Alfa-2b treatment.
-
Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
-
Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer.
-
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
-
Invited commentary.
-
Is NNT AOK?
-
Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?
-
Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine.
-
Isolated Central Nervous System Chloroma as a Presenting Sign of Relapsed Pediatric Acute Lymphoblastic Leukemia.
-
Isolated tumor cells in breast cancer.
-
Keloid Excision and Adjuvant Treatments: A Network Meta-analysis.
-
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.
-
Laser suture lysis after mitomycin C trabeculectomy.
-
Leiomyosarcoma in childhood and adolescence.
-
Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis.
-
Limited-stage small-cell lung cancer (stages I-III): observations from the National Cancer Data Base.
-
Linking evidence-based medicine therapeutic summary measures to clinical decision analysis.
-
Liver metastases from breast cancer: long-term survival after curative resection.
-
Local failure in resected N1 lung cancer: implications for adjuvant therapy.
-
Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial).
-
Locally advanced pancreatic cancer.
-
Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.
-
Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial.
-
Long-term results of therapy for stage C neuroblastoma.
-
Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer.
-
Long-term survival following total sacrectomy with reconstruction for the treatment of primary osteosarcoma of the sacrum. A case report.
-
Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy.
-
Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study.
-
Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial.
-
Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302).
-
MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer.
-
MSH6 inactivation and emergent temozolomide resistance in human glioblastomas.
-
Magnetic resonance imaging: a potential tool in assessing the addition of hyperthermia to neoadjuvant therapy in patients with locally advanced breast cancer.
-
Malignant gliomas in older adults with poor prognostic signs. Getting nowhere, and taking a long time to do it.
-
Management of Male Breast Cancer: ASCO Guideline.
-
Management of locally advanced adenocarcinoma of the pancreas.
-
Management of resectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria.
-
Management of tumor bed cysts after chemotherapeutic wafer implantation. Report of four cases.
-
Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance).
-
Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy.
-
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
-
Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.
-
Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.
-
Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma.
-
Minimally invasive gastrectomy for gastric cancer: A national perspective on oncologic outcomes and overall survival.
-
Mitomycin C-augumented trabeculectomy with postoperative wound modulation in pediatric glaucoma.
-
Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy.
-
Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy.
-
Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial.
-
Molecular prediction of recurrence of breast cancer.
-
Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
-
Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
-
Multifocal inflammatory leukoencephalopathy after fluorouracil and levamisole therapy for colon cancer.
-
Multiplatform computational analysis of mast cells in adrenocortical carcinoma tumor microenvironment.
-
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
-
Multiple myeloma.
-
Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.
-
Myeloid growth factors.
-
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.
-
NCCN Guidelines Insights: Bone Cancer, Version 2.2017.
-
Nationwide trends and outcomes associated with neoadjuvant therapy in pancreatic cancer: An analysis of 18 243 patients.
-
Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma.
-
Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons' Referrals.
-
Neoadjuvant chemoradiation for adenocarcinoma of the pancreas.
-
Neoadjuvant chemoradiation for adenocarcinoma of the pancreas.
-
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration.
-
Neoadjuvant chemotherapy in breast cancer: what questions remain?
-
Neoadjuvant hormonal therapy for ductal carcinoma in situ: trial design and preliminary results.
-
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
-
Neuroendocrine small cell carcinoma of the uterine cervix: what disease? What treatment? Report of ten cases and a review of the literature.
-
Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC Trial.
-
Never too old? Age should not be a barrier to enrollment in cancer clinical trials.
-
New Developments in the Management of Cutaneous Squamous Cell Carcinoma.
-
No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database.
-
Nodal Response to Neoadjuvant Chemotherapy Predicts Receipt of Radiation Therapy After Breast Cancer Diagnosis.
-
Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.
-
Nonoperative management of non-small cell lung cancer: the current cancer and leukemia group B experience.
-
Novel Therapeutic Interventions Early in the Disease Trajectory: Drug Development Beyond the Refractory Setting.
-
Novel intronic DICER1 variation associated with pleuropulmonary blastoma in two siblings.
-
Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance).
-
ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.
-
Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumors.
-
Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715).
-
Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts.
-
Outcomes in surgical stage I uterine papillary serous carcinoma.
-
Outcomes of Cytoreductive Surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality.
-
Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy.
-
Ovarian cancer, version 3.2012.
-
Overall survival or other clinical benefits from adjuvant selective intraarterial chemotherapy in patients undergoing curative liver resection for metastatic colorectal tumor.
-
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
-
PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN.
-
Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer.
-
Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology.
-
Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.
-
Pancreatic cancer: future outlook, promising trials, newer systemic agents, and strategies from the Gastrointestinal Intergroup Pancreatic Cancer Task Force.
-
Partner status moderates the relationships between sexual problems and self-efficacy for managing sexual problems and psychosocial quality-of-life for postmenopausal breast cancer survivors taking adjuvant endocrine therapy.
-
Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?
-
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
-
Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis.
-
Pathologic response after neoadjuvant carboplatin and weekly paclitaxel for early-stage lung cancer: a Brown University oncology group phase II study.
-
Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome.
-
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.
-
Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.
-
Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer.
-
Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
-
Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
-
Pediatric melanoma.
-
Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma.
-
Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis.
-
Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases.
-
Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
-
Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer.
-
Peritoneal surface disease with synchronous hepatic involvement treated with Cytoreductive Surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
-
Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907).
-
Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer.
-
Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.
-
Phase I evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma.
-
Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer.
-
Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
-
Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer.
-
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411.
-
Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer.
-
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.
-
Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.
-
Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.
-
Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
-
Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis.
-
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.
-
Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130.
-
Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.
-
Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).
-
Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation.
-
Population-based assessment of emergency room visits and hospitalizations among women receiving adjuvant chemotherapy for early breast cancer.
-
Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort.
-
Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with greater than or equal to 10 positive axillary lymph nodes. Cancer and Leukemia Group B.
-
Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.
-
Postoperative chemotherapy and delayed radiation in infants and very young children with choroid plexus carcinomas. The Pediatric Oncology Group.
-
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704.
-
Practical Treatment Strategies and Future Directions After Progression While Receiving CDK4/6 Inhibition and Endocrine Therapy in Advanced HR+/HER2- Breast Cancer.
-
Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.
-
Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS+HIPEC) with preoperative FACT-C (Functional Assessment of Cancer Therapy) and patient-rated performance status.
-
Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.
-
Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium.
-
Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs).
-
Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy.
-
Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience.
-
Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
-
Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas.
-
Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.
-
Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas.
-
Preoperative chemotherapy and radiation therapy for locally advanced primary and recurrent rectal carcinoma. A report of surgical morbidity.
-
Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience.
-
Preoperative concurrent chemotherapy and radiotherapy in rectal cancer patients.
-
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.
-
Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer.
-
Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies.
-
Preoperative radiotherapy for rectal cancer: benefits and controversies.
-
Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study.
-
Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
-
Primary pediatric intraspinal sarcomas. Report of 3 cases.
-
Primary systemic therapy in HER2-amplified breast cancer: a clinical review.
-
Primary treatment of advanced ovarian cancer: how does the 'real world' practice?
-
Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy?
-
Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.
-
Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients.
-
Prognostic significance of parapharyngeal space venous plexus and marrow involvement: potential landmarks of dissemination for stage I-III nasopharyngeal carcinoma.
-
Prognostic significance of primary tumor sidedness in patients undergoing liver resection for metastatic colorectal cancer.
-
Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma.
-
Promising survival and concomitant radiation plus temozolomide followed by adjuvant temozolomide.
-
Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer.
-
Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45).
-
Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation.
-
Quality measures for the use of adjuvant chemotherapy and radiation therapy in patients with colorectal cancer: a systematic review.
-
Quality of life after adjuvant chemotherapy for breast cancer.
-
Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
-
Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907.
-
Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance).
-
Racial and ethnic differences in adjuvant hormonal therapy use.
-
Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer.
-
Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing.
-
Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer.
-
Radiation and chemotherapy in the treatment of esophageal cancer.
-
Radiation therapy in the treatment of cholangiocarcinoma.
-
Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
-
Radical prostatectomy and the effect of close surgical margins: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
-
Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin.
-
Radiology quiz case 2. Docetaxel (Taxotere)-induced photosensitivity.
-
Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer.
-
Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.
-
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.
-
Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012.
-
Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114).
-
Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.
-
Rapid-fractionation pre-operative chemoradiation for malignant periampullary neoplasms.
-
Receptor tyrosine kinases as rational targets for prostate cancer treatment: platelet-derived growth factor receptor and imatinib mesylate.
-
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.
-
Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection.
-
Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma.
-
Regional spread of cutaneous squamous cell carcinoma of the face via facial vein tumor thrombus: a case report.
-
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.
-
Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer.
-
Reliable data on 5- and 10-year survival provide accurate estimates of 15-year survival in estrogen receptor-positive early-stage breast cancer.
-
Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial.
-
Renal toxicity of ifosfamide in pilot regimens of the intergroup rhabdomyosarcoma study for patients with gross residual tumor.
-
Resection of lymph node metastases influences survival in stage IIIC endometrial cancer.
-
Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
-
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse.
-
Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy.
-
Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group.
-
Results of recent large myocardial infarction trials, adjunctive therapies, and acute myocardial infarction: improving outcomes.
-
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial.
-
Retrospective study of the effect of comorbidity on use of adjuvant chemotherapy in older women with breast cancer in a tertiary care setting.
-
Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation.
-
Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).
-
Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer.
-
Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer.
-
Role of Chemotherapy and Radiation Therapy in the Management of Gastric Adenocarcinoma.
-
Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer-a distinct view on lymph node yield.
-
Role of postmastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancer.
-
Role of radiation therapy in patients with resectable pancreatic cancer.
-
Roundtable panel discussion: the role of glycoprotein IIb-IIIa receptor inhibitors in acute ischemic coronary syndromes.
-
Routine use of zoledronic acid in early-stage breast cancer.
-
Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial.
-
Safety of immediate transverse rectus abdominis myocutaneous breast reconstruction for patients with locally advanced disease.
-
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer.
-
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer.
-
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
-
Short-course androgen ablation combined with external-beam radiation therapy and low-dose-rate permanent brachytherapy in early-stage prostate cancer: a matched subset analysis.
-
Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer.
-
Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
-
Sildenafil exposure and hemodynamic effect after stage II single-ventricle surgery.
-
Simultaneously detected bilateral testicular cancer of different histopathological origin--a challenging situation for the urologist.
-
Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101.
-
Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.
-
Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301).
-
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer.
-
Sphincter preservation in rectal cancer. Local excision followed by postoperative radiation therapy.
-
Sphincter-sparing treatment for distal rectal adenocarcinoma.
-
Squamous cell carcinoma of the oropharynx and hypopharynx.
-
Stage III lung cancer: two or three modalities? The continued role of thoracic radiotherapy.
-
Staging of pancreatic cancer before and after neoadjuvant chemoradiation.
-
Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers.
-
Stopping a clinical trial early: frequentist and Bayesian approaches applied to a CALGB trial in non-small-cell lung cancer.
-
Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy.
-
Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer.
-
Surgery, hyperfractionated craniospinal irradiation, and adjuvant chemotherapy in the management of supratentorial embryonal neuroepithelial neoplasms in children.
-
Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer.
-
Surgical Resection of the Primary Tumor in Women With De Novo Stage IV Breast Cancer: Contemporary Practice Patterns and Survival Analysis.
-
Surgical candidacy and treatment initiation among women with cervical cancer at public referral hospitals in Kampala, Uganda: a descriptive cohort study.
-
Surgical complexity score and role of laparoscopy in women with advanced ovarian cancer treated with neoadjuvant chemotherapy.
-
Surgical management of cutaneous melanoma: current practice and impact on prognosis.
-
Surgical readmission and survival in women with ovarian cancer: Are short-term quality metrics incentivizing decreased long-term survival?
-
Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV).
-
Surgical strategies and outcomes after induction therapy for non-small cell lung cancer.
-
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data.
-
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
-
Survival Advantage With Adjuvant Chemotherapy for Locoregionally Advanced Rectal Cancer: A Veterans Health Administration Analysis.
-
Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.
-
Symptom communication in breast cancer: relationships of holding back and self-efficacy for communication to symptoms and adjustment.
-
Synchronous colorectal liver metastases: the "surgeon as oncologist" perspective.
-
Systemic chemotherapy for urothelial cancer.
-
Systemic therapy for older women with breast cancer.
-
T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment.
-
Taking a Second Look at Neoadjuvant Endocrine Therapy for the Treatment of Early Stage Estrogen Receptor Positive Breast Cancer During the COVID-19 Outbreak.
-
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
-
Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer.
-
Technical advances in the treatment of patients with rectal cancer.
-
Temporal trends in the management of potentially resectable lung cancer.
-
Testicular cancer. Clinical practice guidelines.
-
Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET).
-
The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy.
-
The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB).
-
The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP).
-
The Effect of Timing of Adjuvant Therapy on Survival After Esophagectomy.
-
The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part I: Early-Stage Disease.
-
The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer.
-
The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-negative Esophageal Adenocarcinoma.
-
The Pedunculated Pretender: A Case of Invasive Anorectal Mucosal Melanoma.
-
The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma.
-
The Role of Targeted Therapy in the Management of High-Risk Resected Kidney Cancer: What Have We Learned and How Will It Inform Future Adjuvant Trials.
-
The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma.
-
The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence.
-
The benefits of discussing adjuvant therapies one at a time instead of all at once.
-
The clinical management of chondrosarcoma.
-
The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance.
-
The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma.
-
The effect of darbepoetin alfa on growth, oxygenation and radioresponsiveness of a breast adenocarcinoma.
-
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance).
-
The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer.
-
The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial.
-
The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced primary rectal and rectosigmoid cancer.
-
The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436).
-
The impact of adjuvant endocrine therapy on reducing the risk of distant metastases in hormone-responsive breast cancer.
-
The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.
-
The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study.
-
The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
-
The impact of sharing results of a randomized breast cancer clinical trial with study participants.
-
The influence of adjuvant therapy on survival in patients with indeterminate margins following surgery for non-small cell lung cancer.
-
The landscape of contemporary clinical trials for untreated metastatic clear cell renal cell carcinoma.
-
The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance).
-
The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
-
The role of androgen deprivation therapy combined with prostate brachytherapy.
-
The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
-
The role of neoadjuvant chemotherapy, lymph node dissection, and treatment delay in patients with muscle-invasive bladder cancer undergoing partial cystectomy.
-
The role of optimal debulking in advanced stage serous carcinoma of the uterus.
-
The significance of distant metastases in breast cancer.
-
The surgeon and adjuvant therapy for stage II colon cancer.
-
The treatment of colorectal carcinoma: standard chemotherapy and beyond.
-
The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience.
-
Thirty years of rectal cancer research: a brief history.
-
Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer.
-
Thrombosis and drug-eluting stents: an objective appraisal.
-
Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer.
-
Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study.
-
Timing of local and distant failure in resected lung cancer: implications for reported rates of local failure.
-
Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis.
-
Total neoadjuvant therapy for rectal cancer: An emerging option.
-
Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer.
-
Treatment and outcome of 82 patients with angiosarcoma.
-
Treatment of high-stage bladder cancer: case for adjunctive chemotherapy.
-
Treatment of newly diagnosed glioblastoma multiforme.
-
Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors.
-
Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival.
-
Treatment systems guidelines for primary rectal cancer from the 1996 Patterns of Care Study.
-
Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States.
-
Treatment-induced changes in vocal cord mobility and subsequent local recurrence after organ preservation therapy for laryngeal carcinoma.
-
Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer.
-
Trends in Primary Gallbladder Cancer Incidence and Incidence-based Mortality in the United States, 1973 to 2015.
-
Trends in management of ureteral urothelial carcinoma and effects on survival: a hospital-based registry study.
-
Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy?
-
Understanding the adverse event experience in the S-TRAC adjuvant trial of sunitinib for high-risk renal cell carcinoma.
-
Undertreatment of obese women receiving breast cancer chemotherapy.
-
Update on combined-modality treatment options for pancreatic cancer.
-
Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy.
-
Updates in adjuvant systemic therapy for melanoma.
-
Use and impact of adjuvant chemotherapy in patients with resected non-small cell lung cancer.
-
Use of 1,25α dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model.
-
Use of molecular biomarkers to inform adjuvant therapy for colon cancer.
-
Utilization of neoadjuvant chemotherapy in high-risk, node-negative early breast cancer.
-
Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survival.
-
Variations in cancer care for adolescents and young adults (AYAs) with ductal carcinoma in situ.
-
Ventricular-Arterial Coupling in Breast Cancer Patients After Treatment With Anthracycline-Containing Adjuvant Chemotherapy.
-
Vinorelbine (Navelbine) in non-small cell lung cancer: future directions.
-
Volume of resection in patients treated with breast conservation for ductal carcinoma in situ.
-
Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact?
-
Well differentiated astrocytoma occurring nine years after radiation therapy for medulloblastoma.
-
What threshold for adjuvant therapy in older breast cancer patients?
-
What's new in neoadjuvant therapy for breast cancer?
-
Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?
-
Women's experiences with genomic testing for breast cancer recurrence risk.
-
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809.
-
[Adjuvant therapy of surgically removed stage I melanoma].
-
[Primary chemotherapy in the treatment of breast cancer].
-
[Treatment of primary cancer of the breast in elderly women. Role of hormone therapy].
-
p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.
-
Keywords of People
-
-
Abbruzzese, James,
D. C. I. Distinguished Professor of Medical Oncology,
Medicine, Medical Oncology
-
Barker, Piers Christopher Andrew,
Professor of Pediatrics,
Pediatrics, Cardiology
-
Berchuck, Andrew,
James M. Ingram Distinguished Professor of Gynecologic Oncology,
Obstetrics and Gynecology, Gynecologic Oncology
-
Cohen, Seth Morris,
Professor of Head and Neck Surgery & Communication Sciences,
Head and Neck Surgery & Communication Sciences
-
Cohen-Wolkowiez, Michael,
Professor of Pediatrics,
Pediatrics, Infectious Diseases
-
Craciunescu, Oana,
Professor of Radiation Oncology,
Radiation Oncology
-
Esclamado, Ramon Mitra,
Professor Emeritus of Head and Neck Surgery & Communication Sciences,
Head and Neck Surgery & Communication Sciences
-
Jowell, Paul Simon,
Professor of Medicine,
Medicine, Gastroenterology
-
Lee, Walter T,
Professor of Head and Neck Surgery & Communication Sciences,
Radiation Oncology
-
McLendon, Roger Edwin,
Professor of Pathology,
Pathology
-
Reed, Shelby Derene,
Professor in Population Health Sciences,
Duke Science & Society
-
Sampson, John Howard,
Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine,
Biomedical Engineering
-
Stinnett, Sandra Sue,
Associate Professor of Biostatistics & Bioinformatics,
Biostatistics & Bioinformatics
-
Turkington, Timothy Garvey,
Associate Professor in Radiology,
Radiology